← Leaderboards
Mengjun Wang
3dt Holdings, Llc
$2,210,382
Attributed
$6,268,746
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2017–20$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
Funding mix
By agency
NIH$6,268,746 · 7
By mechanism
R44$4,420,797 · 2
R43$1,847,949 · 5
Top collaborators
- Ghassan S Kassab9 shared
- Terry Hubbard3 shared
- William Combs1 shared
- Gregory S Kelley1 shared
- Xiao Lu1 shared
- Aditya Pandit1 shared
Most similar at 3dt Holdings, Llc
Same institution · by research overlap
- Ghassan S Kassab$29,569,425
- Terry Hubbard$1,720,595
- Gregory S Kelley$857,314
- Xiao Lu$248,206
- Kyle Bates$142,704
Others in their field
Other Emerging Leaders on “Safety”
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
- Kimberly Smith · Ppd Development Lp$122,008,792
- Klaus Romero · Critical Path Institute$90,404,592
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$75,904,237
- Yunda Huang · Fred Hutchinson Cancer Center$70,809,823
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
Research focus
SafetyOperative Surgical ProceduresFamily SuidaeAnimalsCostTissuesLeadDesignValidationHypertensionVenousDevicesChronicBaseHealth Care CostsPressureVenous SystemEdemaCardiacIschemiaAffectInstitutesIn VivoAnimal Model
Grant awards (9)
Left Atrial Appendage Inversion to Prevent Stroke$365,660
R43 · FY2020 · HL · contact PI
New Access Kit for Lymphatic Interventions$339,866
R43 · FY2020 · GM
Device for Treatment of Cardiac No-Option Patients$991,925
R44 · FY2019 · HL · contact PI
HLS-Diagnostic Balloon in Novel Venous Disease Model$364,201
R43 · FY2019 · HL
Device for Treatment of Cardiac No-Option Patients$1,432,551
R44 · FY2018 · HL · contact PI
Mild Hypothermia Catheter for Reperfusion Injury$1,140,998
R44 · FY2018 · HL
Novel Biological Tissue for Vascular Patch$419,085
R43 · FY2018 · HL · contact PI
Mild Hypothermia Catheter for Reperfusion Injury$855,323
R44 · FY2017 · HL
HLS-Animal Model and Treatment of Chronic Venous Insufficiency$359,137
R43 · FY2017 · HL · contact PI